ASTM » Topics » Item 9.01 Financial Statements and Exhibits.

This excerpt taken from the ASTM 8-K filed Feb 18, 2010.

Item 9.01. Financial Statements and Exhibits.

    Exhibit 99.1.       Press release dated February 18, 2010


SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Aastrom Biosciences, Inc.
(Registrant)

February 18, 2010
(Date)
  /s/   TIMOTHY M. MAYLEBEN
Timothy M. Mayleben
Chief Executive Officer and President


  Exhibit Index
  99.1 Press release dated February 18, 2010






This excerpt taken from the ASTM 8-K filed Feb 9, 2010.
Item 9.01. Financial Statements and Exhibits.
 
Exhibit 99.1. Press release dated February 9, 2010
 
 
 
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   
Aastrom Biosciences, Inc.
(Registrant)
 
February 9, 2010
(Date)
 
/s/ TIMOTHY M. MAYLEBEN
Timothy M. Mayleben
Chief Executive Officer and President
 
 
 
Exhibit Index
 
99.1
Press release dated February 9, 2010
 
 

 
 

 

This excerpt taken from the ASTM 8-K filed Jan 27, 2010.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
January 27, 2010   By:   /s/ Timothy M. Mayleben
       
        Name: Timothy M. Mayleben
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
4.1
  Warrant Agreement for Class A Warrants.
4.2
  Warrant Agreement for Class B Warrants.
99.1
  Press Release dated January 21, 2010.
This excerpt taken from the ASTM 8-K filed Oct 27, 2009.

Item 9.01 Financial Statements and Exhibits.

(c) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
October 27, 2009   By:   /s/ George W. Dunbar, Jr.
       
        Name: George W. Dunbar, Jr.
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
99.1
  Amended Agreement, dated October 23, 2009, between Aastrom Biosciences, Inc. and George W. Dunbar
99.2
  Consulting Agreement, dated October 23, 2009, between Aastrom Biosciences, Inc. and Timothy M. Mayleben
99.3
  Employment Agreement, dated October 23, 2009, between Aastrom Biosciences, Inc. and Timothy M. Mayleben
This excerpt taken from the ASTM 8-K filed Oct 7, 2009.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
October 7, 2009   By:   /s/ George W. Dunbar, Jr.
       
        Name: George W. Dunbar, Jr.
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
99.1
  Press Release dated October 7, 2009
This excerpt taken from the ASTM 8-K filed Jun 12, 2009.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
June 12, 2009   By:   /s/ George W. Dunbar, Jr.
       
        Name: George W. Dunbar, Jr.
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
10.1
  Common Stock Purchase Agreement, dated as of June 12, 2009, by and between the Company and Fusion Capital Fund II, LLC
10.2
  Registration Rights Agreement, dated as of June 12, 2009, by and between the Company and Fusion Capital Fund II, LLC
This excerpt taken from the ASTM 8-K filed May 27, 2009.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
May 27, 2009   By:   /s/ George W. Dunbar, Jr.
       
        Name: George W. Dunbar, Jr.
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
4.1
  Termination Agreement, dated May 27, 2009
This excerpt taken from the ASTM 8-K filed Oct 29, 2008.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
October 29, 2008   By:   /s/ George W. Dunbar, Jr.
       
        Name: George W. Dunbar, Jr.
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
10.1
  Common Stock Purchase Agreement, dated as of October 27, 2008, by and between the Company and Fusion Capital Fund II, LLC.
10.2
  Registration Rights Agreement, dated as of October 27, 2008, by and between the Company and Fusion Capital Fund II, LLC.
This excerpt taken from the ASTM 8-K filed Oct 23, 2008.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
October 23, 2008   By:   /s/ George W. Dunbar, Jr.
       
        Name: George W. Dunbar, Jr.
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
4.1
  Restated Articles, as amended (in electronic format only as of October 17, 2008).
4.2
  Bylaws.
This excerpt taken from the ASTM 8-K filed Jun 18, 2008.

Item 9.01 Financial Statements and Exhibits.

(c) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
June 18, 2008   By:   /s/ George W. Dunbar, Jr.
       
        Name: George W. Dunbar, Jr.
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
99.1
  Press Release dated June 18, 2008
This excerpt taken from the ASTM 8-K filed May 5, 2008.

Item 9.01 Financial Statements and Exhibits.

(c) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
May 5, 2008   By:   /s/George W. Dunbar, Jr.
       
        Name: George W. Dunbar, Jr.
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
99.1
  Press Release dated May 5, 2008
This excerpt taken from the ASTM 8-K filed Apr 8, 2008.

Item 9.01 Financial Statements and Exhibits.

(c) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
April 8, 2008   By:   /s/ George W. Dunbar, Jr.
       
        Name: George W. Dunbar, Jr.
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
99.1
  Press Release dated April 8, 2008
This excerpt taken from the ASTM 8-K filed Mar 14, 2008.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
March 14, 2008   By:   /s/ George W. Dunbar, Jr.
       
        Name: George W. Dunbar, Jr.
        Title: Chief Executive Officer and President


Exhibit Index


     
Exhibit No.   Description

 
10.1
  Amendment to Employment Agreement, dated March 10, 2008, between Aastrom Biosciences, Inc. and Gerald D. Brennan, Jr.
This excerpt taken from the ASTM 8-K filed Oct 19, 2007.

Item 9.01 Financial Statements and Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
October 18, 2007   By:   /s/ Gerald D. Brennan, Jr.
       
        Name: Gerald D. Brennan, Jr.
        Title: Vice President, Administrative & Financial Operations and Chief Financial Officer


Exhibit Index


     
Exhibit No.   Description

 
99.1
  Press Release dated October 18, 2007
This excerpt taken from the ASTM 8-K filed Sep 12, 2007.

Item 9.01 Financial Statements and Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
September 12, 2007   By:   /s/ Gerald D. Brennan, Jr.
       
        Name: Gerald D. Brennan, Jr.
        Title: Vice President, Administrative & Financial Operations and Chief Financial Officer


Exhibit Index


     
Exhibit No.   Description

 
3.01
  Amended and Restated Bylaws of Aastrom Biosciences, Inc.
This excerpt taken from the ASTM 8-K filed Nov 8, 2006.

Item 9.01 Financial Statements and Exhibits.

(a) Not applicable.
(b) Not applicable.
(c) Not applicable.
(d) Exhibits.
99.1 Amended and Restated 2004 Equity Incentive Plan
99.2 Forms of Grant Notice and Stock Option Agreement






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
November 8, 2006   By:   /s/ Gerald D. Brennan, Jr.
       
        Name: Gerald D. Brennan, Jr.
        Title: Vice President, Administrative and Financial Operations; Chief Financial Officer


Exhibit Index


     
Exhibit No.   Description

 
99.1
  Amended and Restated 2004 Equity Incentive Plan
99.2
  Forms of Grant Notice and Stock Option Agreement
This excerpt taken from the ASTM 8-K filed Sep 13, 2006.

Item 9.01 Financial Statements and Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Aastrom Biosciences, Inc.
          
September 13, 2006   By:   /s/ Gerald D. Brennan, Jr.
       
        Name: Gerald D. Brennan, Jr.
        Title: Vice President, Administrative and Financial Operations; Chief Financial Officer


Exhibit Index


     
Exhibit No.   Description

 
99.1
  Press Release dated September 13, 2006
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki